23 research outputs found

    Fabrication and characterization of 1D brushite nanomaterials via sucrose ester reverse microemulsion

    Get PDF
    In the present study, 1-dimensional (1D) brushite nanomaterials were fabricated through sucrose ester based reverse microemulsion for the first time. X-ray diffraction patterns revealed that the nanomaterials possessed brushite crystal phase with trace amount of hydroxyapatite. The size and morphology of brushite crystals were governed by the changes in the aqueous-to-sucrose ester weight ratio at low initial reactant concentration, giving rise to rod-like and fibre-like 1D nanomaterials. Brushite nanorods and nanofibres with average diameters of 25.53 ± 4.60 nm (aspect ratio � 6) and 76.18 ± 19.74 nm (aspect ratio � 40), respectively, had been synthesized. As the reactant concentration increased, it became the key factor in controlling nucleation and crystal growth, rendering the aqueous-to-sucrose ester ratio unimportant. Formation mechanism of various morphologies of brushite crystals is postulated. © 2009 Elsevier Ltd and Techna Group S.r.l

    The Association Between N-Terminal B-Type Natriuretic Peptide and One Year Clinical Outcome in Patients with Acute Myocardial Infarction : A Multicenter Study

    Get PDF
    Background: NT-proBNP is a useful biomarker in the management of heart failure. However, there is conflicting evidence for the prognostic value of NT-ProBNP in acute myocardial infarction (AMI). Objectives: (1) To explore the association between NT-proBNP and 1-year cardiac related mortality in AMI patients. (2) To explore the association between NT-proBNP and 1-year risk of sudden cardiac death or ventricular arrhythmia, readmission for heart failure, readmission for acute coronary syndrome (ACS) and stroke. Methods: We conducted a multicenter, prospective observational study recruiting patients presenting with AMI between 1-August2016 to 31-January-2017, involving 1 cardiology referral center and 4 non-cardiology hospitals. NT-proBNP levels (Alere Triage®, US) were measured within 24 hours of AMI diagnosis. Patients were followed-up for 1 year
    corecore